BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process

Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.

BioVaxys Technology Corp

Announces that results from a collaborative research project conducted in the Bavarian Forest National Park in Germany have recently been published in the European Journal of Wildlife Research.